Monthly Production Of Covishield And Covaxin To Be Scaled Up To 10 Crore And 7.8 Crore By August
Referring To B.1.617 Strain As 'Indian Variant' Is Baseless, Unfounded: Health Ministry
India's Universal Immunisation Program Mechanism To Be Used For Distribution Of Covid-19 Vaccine
